United Services Automobile Association bought a new stake in shares of Itron, Inc. (NASDAQ:ITRI - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,026 shares of the scientific and technical instruments company's stock, valued at approximately $314,000.
Several other institutional investors and hedge funds have also added to or reduced their stakes in the business. Invesco Ltd. lifted its stake in Itron by 2.7% during the first quarter. Invesco Ltd. now owns 2,310,769 shares of the scientific and technical instruments company's stock valued at $242,076,000 after purchasing an additional 59,962 shares during the last quarter. Amundi increased its position in shares of Itron by 18.4% in the first quarter. Amundi now owns 929,407 shares of the scientific and technical instruments company's stock worth $97,313,000 after acquiring an additional 144,361 shares in the last quarter. Nuveen Asset Management LLC increased its position in shares of Itron by 21.5% in the fourth quarter. Nuveen Asset Management LLC now owns 560,478 shares of the scientific and technical instruments company's stock worth $60,857,000 after acquiring an additional 99,142 shares in the last quarter. Wellington Management Group LLP increased its position in shares of Itron by 15.2% in the first quarter. Wellington Management Group LLP now owns 384,152 shares of the scientific and technical instruments company's stock worth $40,244,000 after acquiring an additional 50,789 shares in the last quarter. Finally, Robeco Schweiz AG increased its position in shares of Itron by 1.6% in the first quarter. Robeco Schweiz AG now owns 296,545 shares of the scientific and technical instruments company's stock worth $31,066,000 after acquiring an additional 4,545 shares in the last quarter. 96.19% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling
In other Itron news, SVP John F. Marcolini sold 565 shares of Itron stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $70,800.15. Following the transaction, the senior vice president directly owned 14,396 shares of the company's stock, valued at $1,803,962.76. The trade was a 3.78% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Christopher E. Ware sold 351 shares of the firm's stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $125.31, for a total value of $43,983.81. Following the completion of the sale, the senior vice president owned 19,117 shares of the company's stock, valued at $2,395,551.27. This represents a 1.80% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 3,037 shares of company stock worth $380,566. 1.51% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
ITRI has been the topic of several analyst reports. Johnson Rice downgraded shares of Itron from a "buy" rating to an "accumulate" rating in a research report on Friday, August 1st. JPMorgan Chase & Co. raised shares of Itron from a "neutral" rating to an "overweight" rating and increased their price target for the stock from $128.00 to $145.00 in a research report on Thursday, July 31st. TD Cowen increased their price target on shares of Itron from $139.00 to $145.00 and gave the stock a "buy" rating in a research report on Friday, June 20th. Wall Street Zen raised shares of Itron from a "hold" rating to a "buy" rating in a research report on Saturday, August 2nd. Finally, Stephens set a $130.00 price target on shares of Itron in a research report on Monday, August 4th. Ten research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $136.55.
View Our Latest Analysis on Itron
Itron Stock Performance
Itron stock traded up $0.63 during trading hours on Monday, reaching $120.17. 430,032 shares of the company were exchanged, compared to its average volume of 586,423. The firm has a market cap of $5.49 billion, a price-to-earnings ratio of 20.54, a PEG ratio of 0.66 and a beta of 1.46. The company has a current ratio of 2.04, a quick ratio of 1.75 and a debt-to-equity ratio of 0.48. The stock has a 50-day moving average of $127.60 and a 200 day moving average of $117.63. Itron, Inc. has a 12 month low of $90.11 and a 12 month high of $140.04.
Itron (NASDAQ:ITRI - Get Free Report) last announced its earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.33 by $0.29. The firm had revenue of $606.76 million during the quarter, compared to analysts' expectations of $610.36 million. Itron had a return on equity of 19.69% and a net margin of 11.05%.The company's revenue was down .4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.21 earnings per share. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. As a group, research analysts anticipate that Itron, Inc. will post 5.33 earnings per share for the current year.
About Itron
(
Free Report)
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
Featured Stories

Before you consider Itron, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Itron wasn't on the list.
While Itron currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report